Skip to content

FIT— Can a Dipstick Test Rule Out Bowel Cancer?

NICE Guidelines and the place of the Faecal Immunochemical Test as a triage tool for predicting Bowel Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN49676259
Enrollment
6000
Registered
2017-12-19
Start date
2017-04-01
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer Cancer Colorectal Cancer

Interventions

All participants recruited in the study are asked to complete a stool sample, and return it to the laboratory for FIT analysis. The faecal haemoglobin level are compared to the findings from the colon

Sponsors

Croydon Health Services NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All patients referred under the 2WW urgent referral system and triaged for a colonoscopy examination 2. 18 years of age or older 3. Willing to provide informed consent

Exclusion criteria

Exclusion criteria: 1. Unable to undergo colonoscopy 2. Unable to take adequate stool sample (including those taken during bowel preparation) 3. Unable to give an informed consent due to lack of capacity 4. Unable to give informed consent because of language barrier, when a relative over 18 is unable to translate, a staff member who speaks the same language cannot be found, or online translation service are unsuccessful

Design outcomes

Primary

MeasureTime frame
1. Identify a suitable cut-off for the test 2. Calculate the sensitivity of the test using the chosen cut-off for colorectal polyps

Secondary

MeasureTime frame
1. Calculate the specificity, negative- and positive-predictive values for the chosen cutoff 2. Explore the effects of other prognostic factors on the sensitivity and the suitability of the cut-off value: 2.1. Cancer site 2.2. Site and size of adenomas 3. Assessing the levels of FHb in benign non-neoplastic pathology The above data will be collected from reviewing patient notes and correlated with the faecal haemoglobin detected by the lab.

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 18, 2026